Share

December 2022; 12 (6) CommentaryOpen Access

Cost and Return on Investment of a Team-Based Palliative Care Program for Parkinson Disease

Robert Brett McQueen, Mark Gritz, Drew Kern, Julienne L. Bemski, Ian Shelton, Martha Meyer, Benzi M. Kluger
First published October 26, 2022, DOI: https://doi.org/10.1212/CPJ.0000000000200103
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
238

Share

Article Information

vol. 12 no. 6 429-437
DOI: 
https://doi.org/10.1212/CPJ.0000000000200103
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received December 14, 2022
  • Accepted September 8, 2022
  • First Published October 26, 2022.

Article Versions

Copyright & Usage: 
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Author Disclosures

    1. Robert Brett McQueen, PhD,
    2. Mark Gritz, PhD,
    3. Drew Kern, MD,
    4. Julienne L. Bemski, DO,
    5. Ian Shelton, BA,
    6. Martha Meyer, PhD and
    7. Benzi M. Kluger, MD, MS
  1. Robert Brett McQueen, PhD,
    2. Scientific Advisory Boards:

    1. 1) Merck and Co. advisory board participant

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. Honorary editorial board member at PharmacoEconomics - Open

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Monument Analytics(2) Institute for Clinical and Economic Review

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Eli Lilly

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Research support from PhRMA Foundation(2) Research support from JDRF(3) Research support from Helmsley Charitable Trust

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. (1) Expert witness in 2022

  2. Mark Gritz, PhD,
    3. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. United States Patent 8,116,985 Real time sampling, monitoring and exposure control of test animals, issued February 14, 2012, Johnson; Jerry D., Graves; Steven W., Hong; Seongwon, Bresler; Herbert S., Brooker; Michael J., Gritz; R. MarkUnited States Patent 9,885,085 B2 Apparatus, compositions, and methods for assessment of chronic obstructive pulmonary disease progression among rapid and slow decline conditions, issued February 6, 2018, Hoidal; John, Scholand; Mary Beth, Leppert; Mark F., Paul; Michael S., Gritz; Robert Mark, Pounds; Joel Gardner, Smith; Richard Dale

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1. Colorado Department of Health Care Policy and Financing, Interagency agreement, PI, 2017-20232. Agency for Healthcare Research and Quality, Contract #: HHSP233201500025I, Task Order #: 75P00120F37005, Project Director, 2019-20233. National Institute of Diabetes and Digestive and Kidney Diseases, 1R01DK119478, Co-I, 2019-20244. Patient Centered Outcomes Research Institute, Contract #: HIS-1609-36322, Co-I, 2018-20235. National Institute of Diabetes and Digestive and Kidney Diseases, R18DK127003, Co-I, 2020-20256. Agency for Healthcare Research and Quality, R18HS027079, Co-I, 2019-20227. National Hearth, Lung and Blood Institute, UG3HL151297, Co-I, 2020-20238. National Institute of Diabetes and Digestive and Kidney Diseases, R01DK130176, Co-I, 2021-20269. Patient Centered Outcomes Research Institute, DI-2019C2-17605, Co-I, 2020-202310. National Institute of Neurological Research, 1R01NR016037, Consultant, 2016-2021

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1. The Leona M. And Harry B. Helmsley Charitable Trust, 2204-05191, Co-I, 2021-2024

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Drew Kern, MD,
    4. Scientific Advisory Boards:

    1. Colorado Clinical and Translational Sciences Institute (CCTSI) Data Safety Monitoring Board, and AbbVie Pharmaceutics

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. AbbVie Pharmaceutics and Boston Scientific

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Boston Scientific. Medtronic

    Research Support, Government Entities:

    1. National Institutes of Health

    Research Support, Academic Entities:

    1. University of Colorado Department of Neurology

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Julienne L. Bemski, DO,
    5. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. HCA, physician, 3 years

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Ian Shelton, BA,
    6. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Martha Meyer, PhD and
    7. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Benzi M. Kluger, MD, MS
    8. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. 1) Davis Phinney Foundation - Speaker Honoraria2) Parkinson's Foundation - Speaker Honoraria3) Movement Disorders Society - Speaker Honoraria

    Editorial Boards:

    1. 1) Frontiers in Movement Disorders, Editorial Board2) Annals of Palliative Medicine, Editorial Board3) Palliative Medicine Reports, Editorial Board

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1) National Institutes of Health/NIA, PI, NIH, K02AG062745, 2020-20252) NIH/NINR, PI, R01NR016037, 2016-20213) NIH/NIA, PI, R21AG075524, 2022-24

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1) Patient Centered Outcomes Research Institute

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Skaggs School of Pharmacy and Pharmaceutical Sciences (RBM), University of Colorado Anschutz Medical Campus, Aurora; Department of Health Care Policy and Research (MG, MM), University of Colorado Anschutz Medical Campus, Aurora; Departments of Neurology and Neurosurgery (DK), University of Colorado Anschutz Medical Campus, Aurora; Swedish Medical Center (JLB), Family Residency Program, Denver, CO; Pharmacology Graduate Program (IS), University of Colorado Anschutz Medical Campus, Aurora; and Departments of Neurology and Medicine (BMK), University of Rochester Medical Center, NY.
  1. Correspondence
    Dr. McQueen robert.mcqueen{at}cuanschutz.edu
View Full Text

Article usage

Article usage: October 2022 to February 2023

AbstractFullPdfSource
Oct 2022294044Highwire
Nov 2022218047Highwire
Dec 20224530550Highwire
Jan 2023622061Highwire
Feb 20231914936Highwire

Cited By...

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Alert Me